1TMB
MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMIDE A
Experimental procedure
Spacegroup name | C 1 2 1 |
Unit cell lengths | 70.610, 72.380, 73.350 |
Unit cell angles | 90.00, 101.10, 90.00 |
Refinement procedure
Resolution | 7.000 * - 2.300 |
R-factor | 0.138 |
RMSD bond length | 0.200 |
RMSD bond angle | 5.000 |
Refinement software | PROLSQ |
Data quality characteristics
Overall | |
High resolution limit [Å] | 2.300 * |
Rmerge | 0.043 * |
Total number of observations | 50070 * |
Number of reflections | 12650 * |
Completeness [%] | 79.0 * |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion, hanging drop * | 7.3 * | Skrzypczak, J., (1991) J. Mol. Biol., 221, 1379. * |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | protein | 3.0-3.7 (mg/ml) | |
2 | 1 | drop | sodium phosphate | 0.05 (M) | |
3 | 1 | drop | 0.375 (M) | ||
4 | 1 | drop | 0.5 (mM) | ||
5 | 1 | reservoir | sodium phosphate | 0.1 (M) | |
6 | 1 | reservoir | 1-2 (mM) | ||
7 | 1 | reservoir | PEG8000 | 25-30 (%(v/v)) |